The earnings call reflects a positive turnaround in financial performance with improved net income, gross margins, and operational efficiency. Domestic sales show positive momentum, and there is optimism surrounding the new leadership. However, challenges remain with declining total product sales and international sales, as well as inventory management concerns.

Company Guidance

During the conference call, ImmuCell Corporation provided several key performance metrics for the third quarter of 2025. The company reported an 8% decrease in total product sales compared to the same period in 2024, attributed to restocking their distribution channels earlier in the year. However, domestic sales showed a positive momentum with a 2% increase year-over-year and a 9.5% increase compared to the second quarter of 2025. International sales declined due to shipment timing, but were 15% higher for the nine-month period ending September 30, 2025, compared to the prior year. Net income for the nine months ended September 30, 2025, was $1.8 million, a significant improvement from a net loss of $2.7 million in the same period of 2024. The gross margin improved to 43% from 26% in the third quarter of 2024, which contributed to the positive net income shift. Adjusted EBITDA also showed strong results, with $751,000 for the third quarter and $5.8 million for the trailing twelve months ending September 30, 2025. The company has a capacity expansion goal of supporting $30 million in annual revenue and continues to focus on operational excellence while exploring new market opportunities.

Improved Financial Performance

Net income of $1.8 million during the 9 months ended September 30, 2025, compared to a net loss of $2.7 million during the same period in 2024, marking a $4.5 million improvement.

Gross Margin Enhancement

Gross margin as a percentage of product sales increased to 43% during the third quarter of 2025 from 26% in the third quarter of 2024.

Domestic Sales Growth

Domestic sales were up 2% during the third quarter compared to the third quarter of 2024, and up 9.5% compared to the second quarter of 2025.

Operational and Cost Efficiency

Operating expenses reduced by 7.4% or $543,000 compared to the prior year.

Leadership Transition

Successful CEO succession with Olivier Te Boekhorst joining as President and CEO, bringing over 25 years of leadership experience in animal health.

Immucell (ICCC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ICCC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 24, 2026	2025 (Q4)	- / -	0.058	―	―	―
Nov 13, 2025	2025 (Q3)	- / -0.01	-0.086	82.56% (+0.07)
Aug 14, 2025	2025 (Q2)	- / 0.06	-0.196	128.57% (+0.25)	―
May 14, 2025	2025 (Q1)	- / 0.16	-0.056	387.50% (+0.22)
Feb 25, 2025	2024 (Q4)	- / 0.06	-0.147	139.46% (+0.20)
Nov 13, 2024	2024 (Q3)	- / -0.09	-0.121	28.93% (+0.04)
Aug 13, 2024	2024 (Q2)	- / -0.20	-0.178	-10.11% (-0.02)
May 14, 2024	2024 (Q1)	- / -0.06	-0.299	81.27% (+0.24)
Feb 27, 2024	2023 (Q4)	- / -0.15	-0.215	31.63% (+0.07)
Nov 13, 2023	2023 (Q3)	- / -0.12	-0.085	-42.35% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ICCC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 13, 2025	$6.05	$5.40	-10.74%
Aug 14, 2025	$6.72	$6.10	-9.23%
May 14, 2025	$4.91	$5.30	+7.94%
Feb 25, 2025	$5.10	$5.48	+7.45%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Immucell (ICCC) report earnings?

Immucell (ICCC) is schdueled to report earning on Feb 24, 2026, After Close (Confirmed).

What is Immucell (ICCC) earnings time?

Immucell (ICCC) earnings time is at Feb 24, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ICCC EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing